eClinical Tech News

Nurix Therapeutics has initiated Daybreak, a pivotal, single‑arm phase 2 study of its oral BTK degrader bexobrutideg in relapsed/refractory...

Roche posted a 7% increase in 2025 Group sales at constant exchange rates, with Pharmaceuticals up 9% and Diagnostics...

Roche posted a stronger-than-expected 2025 finish, with group sales up 7% at constant exchange rates to CHF 61.5 billion,...

INmune Bio outlined two near-term catalysts and a tighter clinical focus in an investor update: a mid‑summer 2026 UK...

BrightInsight has raised $13 million from Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners to...

60 Degrees Pharmaceuticals has partnered with Runway Health to expand pre-departure access to Arakoda (tafenoquine), the only once-weekly, broad-spectrum...

Invivyd has enlisted Olympic champion Lindsey Vonn for a national multimedia education campaign on antibodies and infectious disease prevention,...

BrightInsight has expanded its executive leadership team, appointing a new chief operating officer, a senior vice president overseeing market...

Iovance Biotherapeutics has granted inducement stock options for 97,710 shares to 17 newly hired non-executive employees, priced at $2.22...

Virbac closed 2025 with €1.465 billion in revenue, up 7.9% organically at constant exchange rates and scope, with fourth-quarter...